University of South Florida (Site 1043) — Tampa, Florida

University of South Florida (Site 1043) is a clinical research site located in Tampa, Florida, United States 33606.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of South Florida (Site 1043) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Florida (Site 1043)?

University of South Florida (Site 1043) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Florida (Site 1043) conducted?

University of South Florida (Site 1043) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is University of South Florida (Site 1043) accredited by Crixeo Health?

University of South Florida (Site 1043) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Florida (Site 1043)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.